The CONTROLRISK study was designed to determine the cardiovascular risk profile of the hypertensive population attended at primary care and specialist setting in Spain and to investigate whether physicians stratify the risk correctly, according to the 2003 European guidelines. A total of 8920 patients were recruited from primary care (n ¼ 4485) and specialist outpatient clinic (n ¼ 4435). The age criteria was 62.6711.1 years; 51.6% were women. No differences were observed in the severity of hypertension. More than 85% presented other cardiovascular risk factors, similarly in both groups. Target organ damage (TOD) and associated clinical conditions (ACC) were more frequent in specialist setting (57.6 vs 34.3% and 39 vs 28.7%, both Po0.0001). The most common risk factor was age. The most frequently reported TOD was left ventricular hypertrophy (42.3 and 22.1%; Po0.0001).
Introduction
It is a well-known fact that blood pressure (BP) control rates are considered very unsatisfactory in primary care worldwide, and Spain is no exception. [1] [2] [3] [4] [5] [6] [7] [8] [9] But BP control is also far from good even in hospital hypertension units; although the percentage of properly controlled patients is significantly higher in hospital than in population-based surveys or primary healthcare. 10 Nevertheless, guidelines such as JNC-6, 11 WHO/ ISH 2003 12 and European Society of Hypertension/ European Society of Cardiology (ESH/ESC) 2003 13 recommend that high BP therapeutic decisions should be based not only on BP values but also on cardiovascular risk. Therefore, cardiovascular risk stratification must be a priority in the clinical management of hypertensive patients. There are several tables available to stratify the cardiovascular risk, the ESH/ESC guidelines 13 being one of the most useful in clinical practice.
But the truth is that cardiovascular risk stratification in hypertension is most likely to be underused in daily practice. Furthermore, according to recent studies when primary care physicians assess the risk in hypertensive patients they tend to underestimate it.
14-16 However, we do not know if the stratification risk performed by specialists is any better. On the other hand, no studies to date have considered comparing the risk profile of the hypertensive population attended in primary care daily vs that attended in a specialist setting. Hence, we designed the CONTROLRISK study to define the hypertensive population attended in primary care daily and specialist outpatient clinics in Spain and the capacity of both groups of physicians to stratify the risk correctly according to the European guidelines.
Patients and methods

Study population
We performed a cross-sectional and observational survey covering a wide sample of ambulatory patients, aged 18 years or older, with an established diagnosis of essential hypertension. Primary care and specialist physicians were invited to take part including the first 30 hypertensive patients who regularly attended the outpatient clinic for any reason. An informed consent was obtained from all the participants. The study protocol was approved by the appropriate institutional review committee.
The study was conducted by 485 investigators proportionally distributed throughout Spain (245 specialists and 299 general practitioners (GPs)). A complete medical history and a physical examination was performed on each recruited patient under conditions of clinical practice. Data including anthropometrical variables, heart rate and all the parameters that physicians could obtain from the outpatient clinics to stratify the risk according to ESH/ESC guidelines were collected in a specific case report form (CRF). Physicians were asked for BP values, the presence of cardiovascular risk factors (CVRF), target organ damage (TOD) and associated clinical conditions (ACC). All patients had an established diagnosis of essential hypertension, including patients with newly diagnosed hypertension as defined in ESH/ESC 2003 guidelines. 13 Seated BP was measured twice (after 5 min resting and with a 5 min period between them) and the mean of the two values was considered. 
Statistical analysis
Only those patients with more than 80% of data completion were considered for the analysis. Comparison of quantitative parameters between primary care and specialists patients was made with Student's t-test when conditions for parametric analysis were fulfilled (normality and variance homogeneity) or with Mann-Whitney U-test in the other cases. Qualitative parameters were compared using w 2 test. Statistical differences between physician's and central risk assessment were evaluated with 95% confidence intervals for each risk group. Data were analysed with SPSS 10.0 statistical package. A P value o0.05 was considered as significant.
Results
Cardiovascular risk profile of the study population A total of 11 142 patients were initially recruited from primary care (n ¼ 5759) and specialist physicians (n ¼ 5383), most of them being cardiologists (83%). After the database was finalized, and incomplete or inconsistent CRF excluded, the sample size was finally 8920 patients, 4485 from primary care and 4435 from specialists. Mean age was 62.6711.1 years. Women's percentage was 51.6%, higher in primary care than in specialist setting (54.3 vs 48.9%; Po0.0001). Statistically significant differences in height and body mass index between the two populations were also found. Percentage of patients with previously known hypertension was 84.9% in specialists group and 79.4% in primary care (Po0.0001). There were no differences in the severity of hypertension in the two populations; a similar number of 1, 2 or 3 grade hypertensive patients were found in both groups. Most patients had grade 1 (64.6 and 65.4% in specialists and primary care, respectively), and only a small subset (4.8 and 3.8%, respectively) suffered from grade 3 hypertension. Table 1 shows the clinical characteristics of the study population.
Almost 90% of patients in the two groups had one or more CVRF. The presence of TOD and ACC was more frequent in specialist than in primary care patients. In specialist setting, TOD was reported in 57.6% and ACC in 39%. In primary care patients, TOD was present in 34.3% and ACC in 28.7% (both, Po0.0001 vs specialist). The most common CVRF was age (more than 60% in the two groups), and high low-density lipoprotein cholesterol being 45.0% in specialists and 45.4% in primary care. Positive family history was more frequent in GPs' patients (30.6 vs 22.8%). C-reactive protein was not considered for stratification because it had not been determined in most of the patients. The most frequently reported TOD was left ventricular hypertrophy; 22.1% in primary care and almost twice (42.3%) in specialists' patients. Percentage of individuals with slightly elevated creatinine (and/or microalbuminuria) and atherosclerotic plaques were also considerably higher in specialist group than in primary care population (Po0.0001 in the two cases). Ischemic heart disease was the most commonly reported ACC (21.5% in specialist and 13.1% in primary care patients), followed by congestive heart failure. Regarding the other collected CVRF, it is noticeable in the high percentage of sedentarism (about 65%). Tables 2 and 3 Physicians's assessment of cardiovascular risk The risk was significantly higher in specialist than in primary care population. The composite of highand very high-risk groups was 55.8% in specialists and 40.5% in primary care considering the physicians' evaluation, and up to 75.1 and 60.3%, respectively, according to the central classification. Differences were observed between the specialist and the primary care patients risk profile. Statistically significant differences were found when comparing each risk level percentages between physician's and central assessment in the two study populations (except for high-risk level). Central cardiovascular risk assessment and physicians' estimation are presented in Table 4 .
The two groups of physicians frequently underestimated the cardiovascular risk. Specialists correctly classified 54.6% of the patients and GPs classified 48.0% (Po0.05). Low-, medium-and high-risk patients were adequately classified in more than 50% of cases by specialists and GPs. Very high-risk patients were rightly classified only in 44.9% of the cases in specialist setting and in 25.3% in primary care (Po0.05). Table 5 shows the percentages of right classification for each ESH/ESC guidelines risk category, comparing physician and central assessment. One level risk underestimation was observed in 28.6 and 30.9% of patients in specialists and primary care, respectively, whereas a risk underestimation of two levels appeared in 9.7 and 11.2% of all patients. Risk overestimation was markedly less frequent than underestimation in both populations. One level overestimation was present in 7.8% of primary care and in 5.2% of specialists' patients. Figure 1 shows the proportion of patients with correct and wrong estimations in both settings.
Discussion
Although BP control is crucial, clinical guidelines agree that the aim of treatment in hypertensive patients should be focussed not only on BP values, but on the global cardiovascular risk as well.
11-13
The latest European hypertension guidelines emphasize the global assessment of cardiovascular risk, including the identification of hypertension-related lesions. Therefore, it is crucial to determine the risk profile of hypertensive patients. According to the clinical hypertension guidelines, the cardiovascular risk is defined by the presence of CVRF, TOD and ACC. 13 Interestingly, in our study, CVRFs are more prevalent in primary care than in specialist setting. However, as expected TOD and ACC are significantly more prevalent in specialists' population compared to that of GPs. These last two parameters 
test for sex and BMI distribution
Cardiovascular risk in primary care and specialists patients V Barrios et al make that patients attended by specialists exhibit a higher cardiovascular risk profile than those attended in primary care. This implies that intensive therapeutic intervention would result more beneficial in terms of morbidity and mortality reduction in specialist than in primary care setting, as described in previous studies. 14, [17] [18] [19] We analysed how adequately the GPs and the specialists stratify the cardiovascular risk. Our data show that GPs and specialists frequently make incorrect risk stratification in hypertensive patients. Only about half of them (a little more in specialists) are well classified in clinical practice, and this occurs even when a risk stratification table was provided in each CRF. The main reason for the differences detected between physicians and central assessment when comparing the risk stratification could most likely be due to the lack of recognition of the risk by the physicians. 3 Although in some cases physicians overestimate the risk, they more frequently underestimate it, mainly in high-risk patients. But despite underestimation observed in both groups, GPs incorrect, particularly in high-and very high-risk groups. Although the risk-based tables are becoming increasingly common in clinical practice, 14, 17 there are scarce data reporting healthcare professionals' accuracy in using risk tables ( 7, 14 However, the differences in classification methods used make it inadequate to compare statistically physicians' accuracy among these studies. 22, 23 Physicians in Spain mainly use the ESH/ESC 2003 guidelines to stratify the risk of the hypertensive patients. Despite the fact that these guidelines clearly show how to assess CVR, our results show that GPs and specialists make an incorrect estimation of the risk. It is possible that other hypertension guidelines could be more helpful for physicians to make a correct risk stratification. 24 The risk of CV events depends on a number of factors, of which high BP is only a contributing one. An incorrect estimation of the risk based on the physician's perception may have significant impli- 
cations in the clinical management of hypertensive patients. First, because treatment decisions should be taken after a correct estimation of the individual's susceptibility to a cardiovascular event. Second, the consequent risk-benefit ratio of antihypertensive treatment could not be accurately determined if risk assessment is not correct. On the other hand, several authors have outlined that whether or not absolute CVR concept is taken into account, its consequences for the patient should be evaluated in the real practice. 25 Only a cardiovascular prevention trial that selects patients on their absolute CVR should demonstrate that the correct classification can improve treatment and patients outcomes. Camisasca et al. 26 realized that the detection of the risk is somehow frequently independent of the final therapeutic decision of GPs. A marked correlation appears between BP values and therapeutical attitude, regardless of the individual risk. In fact, physicians seem to act basically attending only on BP criteria. Not many studies have been focussed on BP control and on cardiovascular risk profile in primary care hypertensive patients in Spain. [5] [6] [7] [8] [9] There are few studies in primary care, and even fewer in specialists setting. 10, 27 Subsequently, our study gives useful information because it refers to the two hypertensive populations at the same time and compares both. But undoubtedly, the most interesting finding in our study is that risk is usually underestimated even in specialists setting. Data in the literature [28] [29] [30] [31] show that the main barriers in following the experts recommendations are difficult access to patient data, excess of information, minimal time for patients in daily practice and a lack of motivation to change therapeutic habits. Our results show that although an important percentage of hypertensive patients who attend primary care and specialist setting belong to high-or very high-risk groups, there is often an underestimation of the risk in daily practice and this situation may be even worse, because ESH/ESC guidelines stratify a higher proportion of hypertensive patients in the medium and high-risk groups than stratified in the 1999 WHO/ISH guidelines. 32 For example, the measurement of microalbuminuria, is an easy and low-cost determination, according to 2003 ESH/ESC guidelines, and it seems to be a cost-effective screening test to avoid the underestimation of the CVR. 33 This underestimation of the risk probably implies that hypertensive patients could be frequently undertreated, what may have a critical influence in a poor BP control, mainly in high-risk groups. Moreover, these high-risk patients could also be denied of other beneficial interventions such as statins 34 on the basis of underestimation of the risk. Summary table summarizes the key points of our study. Figure 1 Comparison between risk underestimation and overestimation between specialist physicians and primary care. Mean values for all risk categories.
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Cardiovascular risk in primary care and specialists patients V Barrios et al Limitations of the study Although the cross-sectional design has its limitations because it reduces the level of control that can be exercised to reduce variation and bias (e.g. random sampling) or use a more sophisticated statistical approach, combined with qualitative methodology, the large number of patients included in the study and the nature of the end points being measured minimizes this theoretical limitation. Overall, the study was designed to represent clinical practice, giving an accurate picture of the hypertensive population who attend primary care daily and specialist outpatient clinics in Spain. Despite some limitations, this kind of studies may give relevant information from the 'real world' of the daily clinical practice.
